Global Health Limited

NSE MEDANTA.NS

Global Health Limited Price to Sales Ratio (P/S) on January 14, 2025: 8.09

Global Health Limited Price to Sales Ratio (P/S) is 8.09 on January 14, 2025, a -18.08% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Global Health Limited 52-week high Price to Sales Ratio (P/S) is 14.68 on February 23, 2024, which is 81.38% above the current Price to Sales Ratio (P/S).
Global Health Limited 52-week low Price to Sales Ratio (P/S) is 7.86 on October 07, 2024, which is -2.87% below the current Price to Sales Ratio (P/S).
Global Health Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 10.16.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

NSE: MEDANTA.NS

Global Health Limited

CEO	Mr. Pankaj Prakash Sahni
IPO Date	Nov. 18, 2022
Location	India
Headquarters	The Medicity
Employees	9,052
Sector	Health Care
Industries Hospitals & Clinics Pharmaceuticals Telehealth

Description

Global Health Limited, a multi-specialty tertiary care provider, offers healthcare services in India. The company primarily offers treatments in the areas of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. It operates a network of four hospitals in Gurugram, Indore, Ranchi, and Lucknow under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurgaon, India.

Key trends

Past 5 years